EANM guideline on the validation of analytical methods for radiopharmaceuticals

Gillings, N., Todde, S., Behe, M., Decristoforo, C., Elsinga, P., Ferrari, V., Hjelstuen, O., Peitl, P. K., Koziorowski, J., Laverman, P., Mindt, T. L., Ocak, M. & Patt, M., 12-Feb-2020, In : EJNMMI Radiopharmacy and Chemistry. 5, 1, 29 p., 7.

Research output: Contribution to journalArticleAcademicpeer-review

  • Nic Gillings
  • Sergio Todde
  • Martin Behe
  • Clemens Decristoforo
  • Philip Elsinga
  • Valentina Ferrari
  • Olaug Hjelstuen
  • Petra Kolenc Peitl
  • Jacek Koziorowski
  • Peter Laverman
  • Thomas L Mindt
  • Meltem Ocak
  • Marianne Patt

BACKGROUND: To fulfil good manufacturing requirements, analytical methods for the analysis of pharmaceuticals for human and vetinary use must be validated. The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) has published guidance documents on the requirements for such validation activities and these have been adopted by the European Medicines Agency, The U.S. Food and Drug Administration (FDA) and other regulatory bodies. These guidance documents do not, however, fully address all the specific tests required for the analysis of radiopharmaceuticals. This guideline attempts to rectify this shortcoming, by recommending approaches to validate such methods.

RESULTS: Recommedations for the validation of analytical methods which are specific for radiopharmaceutials are presented in this guideline, along with two practical examples.

CONCLUSIONS: In order to comply with good manufacturing practice, analytical methods for radiopharmaceuticals for human use should be validated.

Original languageEnglish
Article number7
Number of pages29
JournalEJNMMI Radiopharmacy and Chemistry
Issue number1
Publication statusPublished - 12-Feb-2020

Download statistics

No data available

ID: 120238220